Large Cap Archives - Page 100 of 437

2 minute read

General Motors Stock Forms Golden Cross With Q4 Earnings Beat; Driven By Profits, Cost Efficiency, 6 EV Debuts

January 31, 11:56 AM

GM stock made a Golden Cross on earnings beat, signaling upward momentum. GM closed FY23 strongly and plans to launch 6 new EV models.

1 minute read

Why Software & Technology Company Roper Shares Are Down Today

By Lekha Gupta

January 31, 11:51 AM

Roper Technologies reported Q4 FY23 results, beating estimates. Revenue up 13%, gross profit and operating income increased. Roper anticipates full year 2024 adjusted EPS below Street view.

ROP

1 minute read

Medical Equipment Maker Thermo Fisher Scientific Clocks 7% Decline In Q4 Organic Sales, Issues Subdued Annual Outlook

By Vandana Singh

January 31, 10:49 AM

"Thermo Fisher Scientific surpasses Q4 revenue expectations at $10.89B, down 5% YoY. Analytical Instruments Segment rises 8.5%. Financial highlights and 2024 revenue guidance.

TMO

1 minute read

Why Rockwell Automation Shares Are Diving Today

By Lekha Gupta

January 31, 10:45 AM

Rockwell Automation reported Q1 FY24 results below expectations. Sales grew 3.6% Y/Y, total ARR grew 20% Y/Y. Adjusted EPS of $2.04 missed consensus.

ROK

2 minute read

Meta Stock Closes Above $400 For First Time In History Ahead Of Q4 Earnings Thursday

By Surbhi Jain

January 31, 10:31 AM

Meta Platforms stock closed above $400 for the first time in history on Jan. 30. The stock made a new all-time and 52-week high, breaching $406.

GSK Upgrades Long-Term Outlook After Q4 Performance, Shingrix Vaccine And Newly Launched RSV Vaccine Shine

By Vandana Singh

January 31, 9:50 AM

GSK's robust Q4 performance with a 21% YoY increase in adjusted operating profit. Arexvy vaccine sales hit £1.2B in 2023. Outlook for 2024, with 5%-7% sales growth and upgraded long-term projections.

GSK

3 minute read

Take Your Ozempic: Why Late Entry Of Rival Weight-Loss Drugs Won’t Floor Novo, Eli Shares

By Neil Dennis

January 31, 9:49 AM

Eli Lilly to report strong Q4 earnings thanks to successful diabetes treatments, while rivals like Novo Nordisk and Pfizer are also vying for a share of the weight-loss market.

AZN

2 minute read

With Bumper $33B Sales, Novo Nordisk Forecasts Double-Digit 2024 Earnings Growth, Boosts Lower Dose Wegovy US Supplies

By Vandana Singh

January 31, 9:38 AM

Novo Nordisk reports impressive Q4 2023 sales of DKK 65.86 billion, up 43% at CER. Explore robust growth in Diabetes and Obesity care, including GLP-1 diabetes and Wegovy. CEO anticipates continued success in 2024 with sales growth of 18%-26% .

NVO

2 minute read

Why Is European Pharma Giant Novartis Stock Trading Lower Today?

By Vandana Singh

January 31, 9:16 AM

Novartis Q4 2023 sales reach $11.42 billion, up 8%. Strong growth in key drugs, Entresto, Kisqali, Kesimpta, Cosentyx, and Pluvicto. Core operating income at $3.8 billion.

NVS

2 minute read

Why Residential REIT Equity Residential Shares Are Up Today

By Lekha Gupta

January 31, 9:12 AM

Equity Residential shares surge after Q4 results. Same-store revenue up 3.9%, FFO per share up 6.4%. Outlook for growth in FY24.

EQR